Directory
>
Miri Halperin Wernli
Miri Halperin Wernli
Executive President | MindMed
Zug, Zug, Switzerland
Miri Halperin Wernli
Summary
Miri Halperin Wernli is a seasoned executive in the pharmaceutical industry, currently serving as the Executive President of MindMed Inc., a company focused on innovative treatments for brain health disorders. With a strong background in biomedical research, clinical development, and general management, Miri has led significant initiatives in global clinical operations and portfolio management. Her previous roles include co-founding Creso Pharma, where she played a pivotal role in cannabis innovation, and serving as Vice President at Actelion Pharmaceuticals, overseeing global clinical development. Miri holds an Executive MBA from Stanford University and a doctorate in Genetics and Experimental Psychology from the University of Geneva. She is passionate about advancing healthcare solutions that enhance patient outcomes and has a wealth of experience in both startup and corporate environments. Miri's leadership style is characterized by a deep commitment to scientific integrity and innovation.
Miri Halperin Wernli
Work Experience
Executive President at
MindMed
August 2020 - Present
Board Member at
Creso Pharma
August 2020 - March 2021
Co-Founder, Group Chief Executive Officer and Executive Director at
Creso Pharma
July 2016 - August 2020
Vice President, Deputy Head Gobal Clinical Development, Global Head Business & Science Affairs at
Actelion (now Janssen Pulmonary Hypertension)
September 2001 - June 2016
Miri Halperin Wernli
Education
Stanford Graduate School of Business, Executive Mba
January 1997 - January 1998
University of Geneva, Dr.
January 1974 - January 1984
Frequently Asked Questions about Miri Halperin Wernli
What is Miri Halperin Wernli email address?
Miri Halperin Wernli's primary email address is ***************@mindmed.co. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Miri Halperin Wernli work for?
Miri Halperin Wernli is a Executive President at MindMed, a company specializing in Commercial physical research.
Where Miri Halperin Wernli graduated from?
Miri Halperin Wernli holds a degree in from Stanford Graduate School of Business.
How can I directly contact Miri Halperin Wernli?
To contact Miri Halperin Wernli directly, you can use the email address ***************@mindmed.co. Complete contact information is available upon registration with Muraena.
Who is Miri Halperin Wernli?
Miri Halperin Wernli is a seasoned executive in the pharmaceutical industry, currently serving as the Executive President of MindMed Inc., a company focused on innovative treatments for brain health disorders. With a strong background in biomedical research, clinical development, and general management, Miri has led significant initiatives in global clinical operations and portfolio management. Her previous roles include co-founding Creso Pharma, where she played a pivotal role in cannabis innovation, and serving as Vice President at Actelion Pharmaceuticals, overseeing global clinical development. Miri holds an Executive MBA from Stanford University and a doctorate in Genetics and Experimental Psychology from the University of Geneva. She is passionate about advancing healthcare solutions that enhance patient outcomes and has a wealth of experience in both startup and corporate environments. Miri's leadership style is characterized by a deep commitment to scientific integrity and innovation.
Miri`s contact details
***************@mindmed.co
Colleagues
Chief Executive Officer
Executive Director, Global Clinical Development
VP of Pharmaceutical Development
Chief Executive Officer
Chief Accounting Officer
Chief Commercial Officer (CCO)
Executive Director, Head Of Clinical Operations
VP of Programs and Portfolio Office and Program Leader
Vice President, Global Marketing, Strategic Insights & Digital Innovation